In our continuing efforts to rationally design effective vaccines, we have taken advantage of information garnered from antigen–antibody complexes of HER-2 protein with clinically important ...

Natural viral proteins cannot constantly be used as optimal vaccines because they do not always stimulate efficiently the immune system. In December 1 Journal of Clinical Investigation, Jeffrey Ahlers ...

Tumor-associated carbohydrate (TAC) antigens are prime candidates for cancer vaccines because of their ... 660) have overcome this obstacle by designing a peptide that mimics a TAC antigen.

Many attempts at cancer immunotherapy have been conducted; however, apart from melanoma, in which impressive clinical responses have been noted in a small minority of patients, the overall results ...

CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has announced it will award US$2 million to Immunethep SA to develop a conjugated peptide-based vaccine to prevent ...

IO Biotech announced promising findings regarding a novel peptide vaccine designed to counter the immunosuppressive effects of Transforming Growth Factor Beta (TGF-β) in solid tumors. The ...

Peptides provide a good platform to develop efficient cancer vaccines or therapeutic agents that can specifically disrupt the network of signaling in this group of receptors. Peptide ...